Short Interest Worth Mentioning Today: Today Windtree Therapeutics Incorporated (NASDAQ:WINT) Reported Decrease in Shorted Shares

November 21, 2016 - By Ellis Scott   ·   0 Comments

Short Interest Worth Mentioning Today: Today Windtree Therapeutics Incorporated (NASDAQ:WINT) Reported Decrease in Shorted Shares

The stock of Windtree Therapeutics Incorporated (NASDAQ:WINT) registered a decrease of 3.96% in short interest. WINT’s total short interest was 269,200 shares in November as published by FINRA. Its down 3.96% from 280,300 shares, reported previously. With 33,400 shares average volume, it will take short sellers 8 days to cover their WINT’s short positions. The short interest to Windtree Therapeutics Incorporated’s float is 4.47%. About 54,440 shares traded hands. Windtree Therapeutics Inc (NASDAQ:WINT) has declined 55.12% since April 19, 2016 and is downtrending. It has underperformed by 58.99% the S&P500.

Windtree Therapeutics, Inc., formerly Discovery Laboratories, Inc., is a biotechnology company. The company has a market cap of $13.31 million. The Firm is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. It currently has negative earnings. The Firm operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment.

WINT Company Profile

Windtree Therapeutics, Inc., formerly Discovery Laboratories, Inc., incorporated on November 6, 1992, is a biotechnology company. The Firm is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. The Firm operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment. The Company’s technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant, and drug delivery technologies being developed to enable non-invasive administration of aerosolized KL4 surfactant.

More notable recent Windtree Therapeutics Inc (NASDAQ:WINT) news were published by: Streetinsider.com which released: “Windtree Therapeutics, Inc. (WINT) Receives Nasdaq Listing Notification” on November 18, 2016, also Prnewswire.com with their article: “Windtree Therapeutics to Present at Stifel 2016 Healthcare Conference” published on November 08, 2016, Prnewswire.com published: “Discovery Labs Changes Name to Windtree Therapeutics, Inc. (NASDAQ: WINT)” on April 18, 2016. More interesting news about Windtree Therapeutics Inc (NASDAQ:WINT) were released by: Prnewswire.com and their article: “Windtree Therapeutics Reports First Quarter 2016 Financial Results and …” published on May 12, 2016 as well as Prnewswire.com‘s news article titled: “Windtree Therapeutics to Host Conference Call and Webcast on Tuesday, October …” with publication date: October 20, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Ellis Scott


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>